Latest Bert Vogelstein Stories
Two-thirds of all adult cancer cases are primarily the result of “bad luck,” according to the authors of a new study appearing in Friday’s edition of the journal Science.
Science philanthropist, Jeffrey Epstein and the founder of the Program for Evolutionary Dynamics at Harvard University has helped fund pivotal research in how to combat colon cancer and specifically
As the Genetics Society of America's Model Organism to Human Biology (MOHB): Cancer Genetics Meeting in Washington, D.C. drew to a close, it was clear that the mantra for drug discovery to treat cancers in the post-genomic era is pathways.
Targeted cancer cell therapies using man-made proteins dramatically shrink many tumors in the first few months of treatment, but new research from Johns Hopkins scientists finds why the cells all too often become resistant, the treatment stops working, and the disease returns.
Johns Hopkins scientists have developed a gene-based test to distinguish harmless from precancerous pancreatic cysts.
Pancreatic tumors are one of the most lethal cancers, with fewer than five percent of patients surviving five years after diagnosis.
Scientists at the Johns Hopkins Kimmel Cancer Center have discovered how two cancer-promoting genes enhance a tumorâ€™s capacity to grow and survive under conditions where normal cells die.
Foundation Expects to Double 2009 Grant Awards to Nearly $4 Million BETHPAGE, N.Y., June 23 /PRNewswire-USNewswire/ -- The Lustgarten Foundation, the nation's largest private supporter of pancreatic cancer research, today announced its first round of 2009 grants, totaling $1.6 million awarded to six leading research centers for early diagnostic tests and better treatment for one of the nation's deadliest cancers.
An international team of cancer experts reported Thursday that cancer is much more complicated than previously believed, and have discovered why curing the disease is so difficult once a tumor has spread.
- A hairdresser.